December 2017
Providence Cancer Institute is currently conducting more than 150 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.
20 clinical trials open to lung cancer patients
 
At Providence Cancer Institute , 20 open studies offer access to promising new therapies for patients with lung cancer. Two of the newest studies are using combined therapies, including immunotherapies, to potentially improve results for patients with advanced non-small cell lung cancer:


All current open studies:
New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.